COO Panoramica delle azioni
The Cooper Companies, Inc. insieme alle sue consociate, sviluppa, produce e commercializza lenti a contatto. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 2/6 |
| Crescita futura | 3/6 |
| Prestazioni passate | 4/6 |
| Salute finanziaria | 5/6 |
| Dividendi | 0/6 |
Premi
Analisi del rischio
COO ha superato i nostri controlli di rischio.
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
US$114.29
FV
13.0% undervalued intrinsic discount8.04%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
5 days ago author updated this narrative
The Cooper Companies, Inc. Concorrenti
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | US$99.48 |
| Massimo di 52 settimane | US$112.38 |
| Minimo di 52 settimane | US$82.22 |
| Beta | 0.99 |
| 1Variazione di 1 mese | -8.11% |
| Variazione a 3 mesi | 3.74% |
| Variazione di 1 anno | 17.72% |
| 3Variazione a 3 anni | -1.23% |
| Variazione a 5 anni | 27.37% |
| Variazione dall'IPO | 1,189.75% |
Notizie e aggiornamenti recenti
We Think Cooper Companies (NASDAQ:COO) Can Stay On Top Of Its Debt
Nov 17
The Cooper Companies: Winning Share In Contact Lens Markets
Oct 09Are Investors Undervaluing The Cooper Companies, Inc. (NASDAQ:COO) By 35%?
Oct 01Returns On Capital At Cooper Companies (NASDAQ:COO) Paint A Concerning Picture
Sep 15Recent updates
We Think Cooper Companies (NASDAQ:COO) Can Stay On Top Of Its Debt
Nov 17The Cooper Companies: Winning Share In Contact Lens Markets
Oct 09Are Investors Undervaluing The Cooper Companies, Inc. (NASDAQ:COO) By 35%?
Oct 01Returns On Capital At Cooper Companies (NASDAQ:COO) Paint A Concerning Picture
Sep 15The Cooper Companies: Still An Expensive Place
Aug 26Investors Interested In The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings
Aug 17Is There Now An Opportunity In The Cooper Companies, Inc. (NASDAQ:COO)?
Jul 30Is There An Opportunity With The Cooper Companies, Inc.'s (NASDAQ:COO) 36% Undervaluation?
Jun 20Cooper Companies: Business Growth Noted, Valuations An Ask
Jun 14Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
May 21With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
May 02Should You Think About Buying The Cooper Companies, Inc. (NASDAQ:COO) Now?
Apr 17The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue
Mar 22Calculating The Intrinsic Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Mar 18The Cooper Companies: I Still Don't See Much Upside
Mar 01These 4 Measures Indicate That Cooper Companies (NASDAQ:COO) Is Using Debt Reasonably Well
Jan 23Cooper Companies: Women Health Business Makes Room For Growth; Path For Margin Expansion
Jan 15When Should You Buy The Cooper Companies, Inc. (NASDAQ:COO)?
Jan 08With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
Dec 24A Look At The Fair Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Nov 30Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
Oct 30What Does The Cooper Companies, Inc.'s (NASDAQ:COO) Share Price Indicate?
Sep 28Cooper Offers A Great Business But A Somewhat Tricky Valuation
Sep 25Here's Why Cooper Companies (NYSE:COO) Can Manage Its Debt Responsibly
Sep 10Calculating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Aug 23Cooper Companies (NYSE:COO) Is Reinvesting At Lower Rates Of Return
Jul 24The Cooper Companies: Valuation Is Too High (Rating Downgrade)
Jul 12When Should You Buy The Cooper Companies, Inc. (NYSE:COO)?
Jun 24Is Cooper Companies (NYSE:COO) Using Too Much Debt?
Jun 08Estimating The Intrinsic Value Of The Cooper Companies, Inc. (NYSE:COO)
May 24Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Apr 23At US$355, Is The Cooper Companies, Inc. (NYSE:COO) Worth Looking At Closely?
Mar 25These 4 Measures Indicate That Cooper Companies (NYSE:COO) Is Using Debt Reasonably Well
Feb 04Cooper Companies: Growth Comes At A High Cost To Equity Holders, Rate Hold
Jan 30Estimating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Jan 19Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Jan 04Cooper Cos. initiated at buy at Mizuho on contact lenses, cataract implants positioning
Dec 22Is It Too Late To Consider Buying The Cooper Companies, Inc. (NYSE:COO)?
Dec 20The Cooper Companies declares $0.03 dividend
Dec 14The Cooper Companies Non-GAAP EPS of $2.75 misses by $0.36, revenue of $848.1M beats by $9.22M
Dec 08Cooper Companies: Questions On Viability Of Future Earnings Upside
Nov 04Are Investors Undervaluing The Cooper Companies, Inc. (NYSE:COO) By 38%?
Oct 18BioSkryb, Cooper ink license deal for genomic technology for women's reproductive health
Oct 18Be Wary Of Cooper Companies (NYSE:COO) And Its Returns On Capital
Oct 03Rendimenti per gli azionisti
| COO | US Medical Equipment | US Mercato | |
|---|---|---|---|
| 7D | -3.9% | -1.2% | -2.1% |
| 1Y | 17.7% | 22.4% | 29.6% |
Ritorno vs Industria: COO ha avuto una performance inferiore rispetto al US Medical Equipment che ha registrato un rendimento 22.4 % nell'ultimo anno.
Rendimento vs Mercato: COO ha avuto una performance inferiore al mercato US che ha registrato un rendimento 29.6 % nell'ultimo anno.
Volatilità dei prezzi
| COO volatility | |
|---|---|
| COO Average Weekly Movement | 3.9% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Prezzo delle azioni stabile: COO non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.
Volatilità nel tempo: La volatilità settimanale ( 4% ) di COO è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 1958 | 15,000 | Al White | www.coopercos.com |
The Cooper Companies, Inc. insieme alle sue consociate, sviluppa, produce e commercializza lenti a contatto. L'azienda opera in due segmenti, CooperVision e CooperSurgical. Il segmento CooperVision fornisce lenti sferiche, tra cui lenti che correggono la miopia e l'ipermetropia, e lenti toriche e multifocali, tra cui lenti che correggono i problemi della vista, come l'astigmatismo, la presbiopia e la miopia, nelle Americhe, in Europa, in Medio Oriente, in Africa e nell'Asia Pacifica.
The Cooper Companies, Inc. Riepilogo dei fondamenti
| COO statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | US$19.84b |
| Guadagni(TTM) | US$359.30m |
| Ricavi(TTM) | US$3.80b |
55.1x
Rapporto P/E5.2x
Rapporto P/SCOO è sopravvalutato?
Vedi Fair Value e analisi di valutazioneGuadagni e ricavi
| COO Conto economico (TTM) | |
|---|---|
| Ricavi | US$3.80b |
| Costo del fatturato | US$1.28b |
| Profitto lordo | US$2.52b |
| Altre spese | US$2.17b |
| Guadagni | US$359.30m |
Ultimi guadagni dichiarati
Jul 31, 2024
Prossima data di guadagno
Dec 05, 2024
| Utile per azione (EPS) | 1.80 |
| Margine lordo | 66.36% |
| Margine di profitto netto | 9.45% |
| Rapporto debito/patrimonio netto | 33.2% |
Come si è comportato COO nel lungo periodo?
Vedi performance storica e confronto